Greg Whitehead

Greg Whitehead

Company: Rubius Therapeutics

Job title: Chief Quality Officer


Panel Discussion & Q&A: Optimizing Next Generation Cell Therapy Starting Materials 6:35 pm

• Discuss how pre-characterized human cellular materials will accelerate cell therapy development • Address the ever-increasing demand for cellular starting materials and review how to increase specific sample cohorts • Deep dive into the benefits of comprehensive multi-omic services and how it can streamline and accelerate cell therapy research • Hear how Discovery Life Sciences…Read more

day: CANCELLED: Recent Advances in Scalable Manufacturing of Cell & Gene Therapies

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.